Morning Overview on MSN

Study links Wegovy to nearly 5x higher sudden sight-loss risk vs Ozempic

A peer-reviewed analysis of U.S. adverse event data has found that patients taking Wegovy face nearly five times the risk of ...
Tax Guru

GSTAT Operational: Complete Guide to GST Appellate Tribunal Appeals

The GST Appellate Tribunal has become operational, completing the GST dispute resolution framework. Taxpayers can now file ...